Position in ADMA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$14,861,931
-$23,479,533 QoQ
Shares Held
1,649,493
-21.5% QoQ
Ownership
0.712%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADMA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Fundsmith LLP holds $35,781,333 across 2 Biotechnology names. ADMA ranks #2 (41.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
844,887 | $20,919,402 | |
| 2 | ADMA |
Adma Biologics, Inc.
This page
|
1,649,493 | $14,861,931 |
All Filings in ADMA
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14,861,931 | 1,649,493 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $38,341,464 | 2,102,054 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||